Header Logo

Connection

FASIHA KANWAL to Ribavirin

Back to Details
This is a "connection" page, showing publications FASIHA KANWAL has written about Ribavirin.
FASIHA KANWAL
Connection Strength
0.180
Ribavirin
  1. Boceprevir and telaprevir in the management of hepatitis C virus-infected patients. Clin Infect Dis. 2012 Jan 01; 54(1):96-104.
    View in: PubMed
    Score: 0.089
  2. Effectiveness of elbasvir/grazoprevir plus ribavirin for hepatitis C virus genotype 1a infection and baseline NS5A resistance. Ann Hepatol. 2023 Mar-Apr; 28(2):100899.
    View in: PubMed
    Score: 0.048
  3. Gaps in the achievement of effectiveness of HCV treatment in national VA practice. J Hepatol. 2012 Feb; 56(2):320-5.
    View in: PubMed
    Score: 0.022
  4. Insurance status and treatment candidacy of hepatitis C patients: analysis of population-based data from the United States. Hepatology. 2011 Mar; 53(3):737-45.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.